SCHEMBL8019479

SCHEMBL8019479

CNc1nc2c(S(=O)(=O)c3ccc(F)cc3)nnn2c2ccc(C)cc12

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.60
ALDH1A1 P00352 3/20 0.60
GAA P10253 2/20 0.60
KMT2A Q03164 1/20 0.60
MAPT P10636 6/20 0.59
RXFP1 Q9HBX9 6/20 0.58
KDM4E B2RXH2 3/20 0.57
HTR6 P50406 6/20 0.56
POLB P06746 2/20 0.56
RECQL P46063 1/20 0.56
TP53 P04637 2/20 0.52
BLM P54132 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
THRB P10828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8019456 0.86 KDM4E (0.64) HPGDALDH1A1GAAKMT2AMAPT
SCHEMBL8033985 0.85 MAPT (0.68) MAPTRXFP1POLBTP53THRB
SCHEMBL8030786 0.83 RXFP1 (0.65) HPGDALDH1A1GAAMAPTRXFP1
SCHEMBL8021777 0.78 HTR6 (0.56) MAPTRXFP1HTR6POLBTP53
SCHEMBL8021789 0.77 KDM4E (0.64) HPGDALDH1A1GAAKMT2AMAPT
SCHEMBL8021786 0.77 KDM4E (0.72) HPGDALDH1A1GAAKMT2AMAPT
SCHEMBL8032614 0.75 MAPT (0.87) HPGDALDH1A1GAAKMT2AMAPT
SCHEMBL8030932 0.75 RXFP1 (0.79) MAPTRXFP1HTR6POLBTP53
SCHEMBL8030611 0.73 MAPT (0.85) HPGDALDH1A1GAAKMT2AMAPT
SCHEMBL15285549 0.72 HTR6 (1.00) MAPTRXFP1HTR6POLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009093934-A2 SUBSTITUTED 3-SULPHONYL-[1,2,3]TRIAZOLO [1,5-A]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, MEDICINAL PREPARATION AND METHODS FOR THE PRODUCTION THEREOF ALLA CHEM, LLC (US) 2009-07-30 WO disclosed